Abstract
We report the effect of 18-month ciclosporin (CS) treatment in 19 children with steroid-dependent frequently relapsing nephrotic syndrome. CS was started at 3–5 mg/kg per day after remission with steroid therapy, was adjusted to maintain a trough blood level of between 200 and 600 ng/ml and was administered for 6 months (high-dose CS). Then, the dosage of CS was decreased and 2.5 mg/kg per day was administered for the subsequent 12 months (low-dose CS). Only 2 patients had relapses during the initial 6 months of CS therapy. Eight patients had infrequent relapses, 4 had frequent relapses and 7 had no relapses during the 12 months of low-dose CS. Not only did continuation of CS at a lower dosage decrease the relapse rate, it also reduced steroid toxicity, allowed increased growth in 16 of the 19 patients and also decreased obesity scores in 12 of these patients. All of the side-effects that occurred during the 18-month period of CS treatment were reversible and none was serious enough to necessitate discontinuation of therapy. Our 18-month CS treatment was helpful in preventing relapses and reducing steroid toxicity in children with steroid-dependent frequently relapsing nephrotic syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hoyer PF, Krull F, Brodehl J (1986) Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet II: 335
Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of childhood—a 14 month experience. Int J Pediatr Nephrol 7: 69–72
Niaudet P, Tete MJ, Broyer M, Habib R (1988) Cyclosporine and childhood idiopathic nephrosis. Transplant Proc 20: 265–268
Brodehl J, Hoyer PF, Oemar BS, Helmchen U, Wonigeit K (1988) Cyclosporine treatment of nephrotic syndrome in children. Transplant Proc 20: 269–274
Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1988) Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 33: 729–734
Brandis M, Burghard R, Leititis J, Zimmerhockl B, Hildebrandt F, Helmchen U (1988) Cyclosporine A for treatment of nephrotic syndromes. Transplant Proc 20: 275–279
Kitano Y, Yoshikawa N, Tanaka R, Nakamura H, Ninomiya M, Ito H (1990) Ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 4: 474–477
International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101: 514–518
International Study of Kidney Disease in children (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hyper-cellularity. Kidney Int 20: 765–771
Garin EH, Pryor ND, Fennell RS, Richard GA (1978) Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. J Pediatr 92: 304–308
Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306: 451–454
Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Arch Dis Child 62: 1102–1106
Niaudet P (1992) The French Society of Paediatric Nephrology: comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr Nephrol 6: 1–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, R., Yoshikawa, N., Kitano, Y. et al. Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 7, 249–252 (1993). https://doi.org/10.1007/BF00853209
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00853209